Filing Details
- Accession Number:
- 0001104659-21-040327
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-23 16:30:19
- Reporting Period:
- 2021-03-19
- Accepted Time:
- 2021-03-23 16:30:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1707502 | Solid Biosciences Inc. | SLDB | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1315082 | Ra Capital Healthcare Fund Lp | 200 Berkeley Street, 18Th Floor Boston MA 02116 | Yes | No | Yes | No | |
1346824 | Ra Capital Management, L.p. | 200 Berkeley Street, 18Th Floor Boston MA 02116 | Yes | No | Yes | No | |
1384859 | Peter Kolchinsky | C/O Ra Capital Management, L.p. 200 Berkeley Street, 18Th Floor Boston MA 02116 | Yes | No | Yes | No | |
1619841 | M. Rajeev Shah | C/O Ra Capital Management, L.p. 200 Berkeley Street, 18Th Floor Boston MA 02116 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-03-19 | 2,206,685 | $5.75 | 10,916,567 | No | 4 | P | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnote |
Footnotes
- RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The securities reported on this Form 4 are held directly by the Fund. Mr. Shah is a member of the board of directors of the Issuer. The filing of this Form 4 shall not be construed as an admission that either the Adviser, the Adviser GP, or Dr. Kolchinsky is or was for the purposes of Section 16(a), or otherwise, the beneficial owner of any of the reported securities, and they disclaim beneficial ownership of any of the reported securities, except to the extent of any pecuniary interest therein.